ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,920Medicare Part D Prescriptions Filled, Including Refills

Rank: 32 out of 617

$740K Total Retail Price of All Prescriptions

Rank: 21 out of 617

434 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 434 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

21% of this provider’s 434 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 11,314 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
HYDROCODONE-ACETAMINOPHEN 616 476 S3 1 8
LEVOTHYROXINE SODIUM 587 519 2 1
OMEPRAZOLE 501 433 3 3
WARFARIN SODIUM 413 374 4 7
FUROSEMIDE 398 309 5 4
PRAVASTATIN SODIUM 355 292 6 21
GABAPENTIN 334 267 7 16
LISINOPRIL 297 251 8 5
SERTRALINE HCL 293 270 9 20
MELOXICAM 272 241 10 24
DONEPEZIL HCL 217 205 11 30
POTASSIUM CHLORIDE 216 178 12 10
AMLODIPINE BESYLATE 207 182 13 6
METFORMIN HCL 193 167 14 9
ATENOLOL 190 171 15 17
ATORVASTATIN CALCIUM 177 150 16 14
TAMSULOSIN HCL 174 132 17 26
NAMENDA 169 157 18 35
CITALOPRAM HBR 153 107 19 18
SIMVASTATIN 134 129 20 2
ZOLPIDEM TARTRATE 127 80 21 23
CEPHALEXIN 126 103 22 68
GLIMEPIRIDE 115 93 23 33
TRAMADOL HCL 113 97 24 15
NAPROXEN 108 96 25 101
LOSARTAN POTASSIUM 107 99 26 22
PREDNISONE 107 102 26 31
LISINOPRIL-HYDROCHLOROTHIAZIDE 106 102 28 29
ADVAIR DISKUS 103 89 29 38
DOXAZOSIN MESYLATE 99 74 30 79
METOPROLOL TARTRATE 98 80 31 11
CARVEDILOL 97 90 32 19
FENTANYL 96 76 S2 33 45
RANITIDINE HCL 94 92 34 40
ISOSORBIDE MONONITRATE ER 94 91 34 52
ALLOPURINOL 93 80 36 27
METOPROLOL SUCCINATE 92 92 37 12
HYDROCHLOROTHIAZIDE 88 83 38 13
RISPERIDONE 88 72 38 71
LEVETIRACETAM 87 31 40 166
CARBIDOPA-LEVODOPA 85 85 41 69
MIRTAZAPINE 84 57 42 50
PRENATAL PLUS 82 64 43 243
DOXYCYCLINE HYCLATE 81 63 44 113
CRESTOR 80 48 45 28
POLYETHYLENE GLYCOL 3350 78 54 46 32
CYMBALTA 76 66 47 49
METFORMIN HCL ER 73 40 48 72
ESCITALOPRAM OXALATE 73 47 48 65
TRIAMCINOLONE ACETONIDE 71 59 50 102
LANTUS 69 53 51 39
LOSARTAN-HYDROCHLOROTHIAZIDE 68 57 52 46
RISPERDAL CONSTA 63 60 53 209
CIPROFLOXACIN HCL 62 57 54 60
AMLODIPINE BESYLATE-BENAZEPRIL 62 62 54 80
FENOFIBRATE 61 41 56 58
TRAZODONE HCL 61 49 56 51
FLUTICASONE PROPIONATE 60 59 58 36
FAMOTIDINE 59 35 59 54
LEVOFLOXACIN 57 52 60 89
CEFUROXIME 57 47 60 165
ALENDRONATE SODIUM 54 54 62 25
KLOR-CON M10 53 43 63 158
LIDODERM 52 48 64 188
ROPINIROLE HCL 52 40 64 66
ENALAPRIL MALEATE 51 51 66 34
OLANZAPINE 50 17 67 139
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 16, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.